Novo Nordisk, a global pharmaceutical giant renowned for its groundbreaking diab...
In a phase 2 study focused on multiple sclerosis (MS), Roche’s BTK inhibitor, Fe...
Omeros has discontinued a phase 3 trial involving narsoplimab for kidney disease...
Roche’s gene therapy arm, Spark, has made a significant stride in bolstering its...
In a significant breakthrough, Ultragenyx and Mereo’s genetic bone disease treat...
Over two years following the acquisition of the medical information aggregator C...
PepGen’s achievement in receiving FDA clearance to proceed with the phase 1 stud...
Labcorp has introduced a novel blood test aimed at aiding the diagnosis of Alzhe...
The initial perception of a complex treatment landscape in the early stages of n...
Ichnos Sciences has, at last, found a potential buyer for its OX40 eczema ventur...
The FDA has declined Alnylam Pharmaceuticals’ request to expand the approval of ...
Bristol Myers Squibb (BMS) is set to make a substantial entry into the field of ...
GSK has established a strategic partnership with Chongqing Zhifei Biological Pro...
A recently established collaboration between Zeiss Medical Technology and Boehri...
In the context of clinical trials, Novartis has achieved a significant milestone...
Innate Pharma, a prominent player in the biotechnology sector, has encountered a...
